# Safety, Tolerability, Pharmacokinetics and Efficacy of YHD1044

> **NCT01419470** · PHASE1,PHASE2 · COMPLETED · sponsor: **Yuhan Corporation** · enrollment: 24 (actual)

## Conditions studied

- Premature Ejaculation

## Interventions

- **DRUG:** dapoxetine

## Key facts

- **NCT ID:** NCT01419470
- **Lead sponsor:** Yuhan Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2012-05
- **Final completion:** 2012-05
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2012-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01419470

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01419470, "Safety, Tolerability, Pharmacokinetics and Efficacy of YHD1044". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01419470. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*